CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Halucenex Phase II Clinical Trial Update, page-37

  1. deco19
    2,640 Posts.
    lightbulb Created with Sketch. 672
    clock Created with Sketch.
    10/05/23
    11:13
    Post #: 67696663
    It's not cash flow positive. Look at their last quarterly ffs.
    CPH Price at posting: 1.9¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
VMS Venture hits 1,839 TREO at Jupiter in WA with best intersection to date
right-arrow Created with Sketch.
ETM This ASX stock could sue Greenland's government for 4x its annual GDP
right-arrow Created with Sketch.
TLM Talisman expands Rip n Tear with lead grading 7.4% and silver at 59.2g/t in NSW
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
BCA Rock chips of more than 58% manganese guide Black Canyon's future drilling at Wandanya
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.